Apogee Therapeutics, Inc. (APGE)

NASDAQ: APGE · Real-Time Price · USD

68.88

+3.25 (4.95%)

At close: Feb 3, 2026, 4:00 PM EST

68.89

+0.01 (0.01%)

After-hours: Feb 3, 2026, 4:10 PM EST

Apogee Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-253.67	-182.15	-83.99	-43.4
Depreciation & Amortization	1.09	0.19	-	-
Loss (Gain) From Sale of Investments	-8.75	-12.24	-3.07	-
Stock-Based Compensation	41.96	23.33	6.1	2.34
Other Operating Activities	3.48	1.69	0.09	12.44
Change in Accounts Payable	-1.84	-1.07	1.61	0.46
Change in Other Net Operating Assets	-14.74	-0.93	4.49	10.25
Operating Cash Flow	-232.48	-171.17	-74.76	-17.92
Capital Expenditures	-5.08	-1.15	-0.17	-
Investment in Securities	160.5	-299.31	-273.74	-
Investing Cash Flow	155.42	-300.46	-273.91	-
Issuance of Common Stock	65.9	495.11	315.39	-
Other Financing Activities	-	-	-	-0.75
Financing Cash Flow	65.9	495.11	315.39	183.62
Net Cash Flow	-11.16	23.47	-33.28	165.7
Free Cash Flow	-237.56	-172.33	-74.93	-17.92
Free Cash Flow Per Share	-4.08	-3.12	-3.00	-7.28
Levered Free Cash Flow	-143.33	-113.42	-45.5	-
Unlevered Free Cash Flow	-143.33	-113.42	-45.5	-
Change in Working Capital	-16.58	-2	6.11	10.71

Updated Nov 10, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q